Janis Bernat

biotherapeutics & scientific affairs, enthusiastic baker, keen on yoga, tweets are mine

[CERN @CERN]

Five days to go to #LHCRun3!📅💥

For the first time ever, we will witness stable-beam collisions at the world-record energy of 13.6 trillion electronvolts (13.6TeV)!

Join us LIVE 5 July, 16.00 CEST with commentary in five languages as we celebrate this milestone!

[IAPO @IAPOvoice]

How can we co-create better healthcare systems in Africa post Covid-19? Hear directly from opinion shapers and health professionals across the continent 🌍

Register now for our #APC2021, taking place 20-21 July. It's online and FREE! https://t.co/EdmveeuFd5

#BuildBackBetter

[IFPMA @IFPMA]

Yesterday, #ICMRA hosted a workshop with associations from biotech, developing & industrialized countries vaccine manufacturers, as well as innovative biopharmaceutical, generic and biosimilar companies, to discuss regulatory success to date in the #COVID19 response.

[Bigger Laetitia @LaetitiaBigger]

The #global delivery of raw materials & #COVID19 vaccines is hampered by #tradebarriers🚧. In her blog, @kalhaua of IFPMA urges elimination of #trade restrictions to achieve #VaccinEquity.
https://t.co/ilGcoql1D8 @ABPI_UK @IAmBiotech @EFPIA @PhRMA @VaccinesEurope

[IFPMA @IFPMA]

This year’s “Facts & Figures Report” underlines the ongoing commitment of the research-based biopharmaceutical industry to improving the quality of life for all people worldwide. 🌏 #PharmaByNumbers

Find out more ➡️https://t.co/yierzgIhVN

[IFPMA @IFPMA]

Vaccinating the🌏against #COVID19 is our joint responsibility, because no one is safe until everyone is.
Our 5 steps to urgently speed up #VaccinEquity ➡️https://t.co/7tsgviGEM4

@ABPI_UK | @IAmBiotech | @EFPIA | @PhRMA | @VaccinesEurope | @IFPMA | #internationalbiotech

[IFPMA @IFPMA]

Pour de nombreux pays, la création de l'#AfricanMedicinesAgency est la promesse d'une production locale de médicaments et l’essor de pôles d'excellence pour la recherche.

Cette table ronde du 22 juin explorera la vision et la stratégie de l'AMA :
💻 https://t.co/xWDZBWlHdD

[FIP @FIP_org]

Access to medicines & health care during #COVID19 has been enabled for “those who have” & disabled further for “those who have not”, increasing opportunities for SF medicines. — FIP CEO Catherine Duggan on a panel of experts by @FightTheFakes at a side event to #WHA74 yesterday

[Janis Bernat @JBernat2]

Younger generations have a key role to play in the fight against COVID-19. Very proud of my young colleagues who are true #VaccineChamp

[IFPMA @IFPMA]

We are proud to partner with @VaccinesEurope and even prouder of our young colleagues who are joining #TeamVaccines by adding their voices and encouraging young adults to understand why it’s important to get vaccinated against #COVID19.

#VaccineChamp #YouthResponse

[ABPI @ABPI_UK]

Read the piece by our colleague @jnharris1189 on how the UK can
transform clinical research https://t.co/3WP5qaaC6D #ICTD2021

[Janis Bernat @JBernat2]

New technologies have helped improve recruitment of volunteers as well as conduct, monitoring and data capture of #clinicaltrials. How can the lessons from this pandemic be applied to the future for #globalhealth?

https://t.co/BJ5DVWz2sy

@MediaPlanetUK @JBernat2

[IFPMA @IFPMA]

Innovative vaccine manufacturers and biotech companies commit to 5 steps to urgently speed up #COVID19 #VaccinEquity: https://t.co/hRhLAaplPY

[Fight the Fakes Alliance @FightTheFakes]

Fighters, it’s time to act against the growing threat of falsified products produced and sold as treatments and vaccines for #COVID19!

#FightTheFakes and join our event on the sidelines of #WHA74!

Find out more and register here: https://t.co/l6p7lTag3L

[BBC Newsnight @BBCNewsnight]

"Vaccine manufacturing is extremely complex. Taking away the patents wouldn't give you a single additional dose."

@IFPMA Director-General @ThomasCueni says waiving patents for the Covid vaccine might give you the blueprint, "but not the know-how"

#Newsnight

[IFPMA @IFPMA]

Behind the production of millions of safe and effective #COVID19 vaccines is unprecedented collaboration between the global biopharmaceutical industry, biotechs, suppliers and health regulatory authorities around the world. #TeamVaccines #VaccinesWork https://t.co/BnQfEmYqgz

[IFPMA @IFPMA]

Vaccines bring us closer to a world without pandemics. Hear the stories of the people working behind the scenes on #COVID19 vaccines and helping to get the vaccines to the people who need them most. #VaccinesWork #TeamVaccines

https://t.co/uEC0ysEo5U

[IFPMA @IFPMA]

In his latest blog, @IFPMA ADG Greg Perry reflects on the top 5 takeaways on expanding manufacturing in Africa that emerged from the summit on organized by the @_AfricanUnion and the @AfricaCDC.

➡️ https://t.co/mQg0FDHaXK

[IFPMA @IFPMA]

In this interview, @IFPMA Paula Barbosa talks about the challenges of scaling up vaccine manufacturing capacity as we're working towards the shared goal of #OneWorldProtected.

[IFPMA @IFPMA]

The people developing #COVID19 vaccines want their families and friends to get back to normal life too. That’s why we’ve come together like never before, working to advance the science and help make vaccines available. #TeamVaccines https://t.co/grIeW5mVOs

[IFPMA @IFPMA]

My brother has had cancer during the pandemic. It has been terribly worrying for me and my family. I know by getting vaccinated when the time comes, we’ll not only protect ourselves, we’ll also help those who are at risk from other diseases. #TeamVaccines https://t.co/TfdMJJTibH